Abstract
In the US and Europe, birth defects are the leading cause of infant mortality. Among birth defects, Congenital Heart Disease (CHD) occurs in approximately 8 out of 1000 live births, affects 1.3 million newborns per year worldwide, and has the highest mortality rate. While there is evidence to indicate that CHD does have a genetic basis, most of the CHD burden remains unexplained genetically. Fortunately, new genomics technologies are enabling genetic analyses of CHD patients. Whole exome sequencing of trios as well as copy number variations assayed by high-density SNP arrays can now be obtained at high efficiency and relatively low cost. These efforts are identifying a number of sequence variations in patients with CHD, but only a small percentage have second unrelated alleles to validate them as disease causing. Importantly, most of these candidate genes do not have an identified molecular mechanism implicating them in cardiac development. Therefore, there is a pressing need to develop rapid functional assays to evaluate candidate genes for a role in cardiac development, and then to investigate the underlying developmental mechanisms. Most recently, the advent of CRISPR/Cas9 genome editing technology has greatly enhanced the ability to manipulate and observe the function of the genome in model systems and cell culture. Incorporating the power of a developmental system such as Xenopus tropicalis with the CRISPR/Cas9 system and the microscale imaging modality optical coherence tomography (OCT), the analysis of thousands of different genes in cardiac development becomes possible.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jin SC, Homsy J, Zaidi S et al (2017) Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet. https://doi.org/10.1038/ng.3970
Homsy J, Zaidi S, Shen Y et al (2015) De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science 350:1262–1266. https://doi.org/10.1126/science.aac9396
Fakhro KA, Choi M, Ware SM et al (2011) Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning. Proc Natl Acad Sci U S A 108:2915–2920. https://doi.org/10.1073/pnas.1019645108
Choi M, Scholl UI, Ji W et al (2009) Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 106:19096–19101. https://doi.org/10.1073/pnas.0910672106
Fraser SE, Harland RM (2000) The molecular metamorphosis of experimental embryology. Cell 100:41–55
Hirsch N, Zimmerman LB, Grainger RM (2002) Xenopus, the next generation: X. tropicalis genetics and genomics. Dev Dyn 225:422–433. https://doi.org/10.1002/dvdy.10178
Khokha MK, Chung C, Bustamante EL et al (2002) Techniques and probes for the study of Xenopus tropicalis development. Dev Dyn 225:499–510. https://doi.org/10.1002/dvdy.10184
Bhattacharya D, Marfo CA, Li D et al (2015) CRISPR/Cas9: an inexpensive, efficient loss of function tool to screen human disease genes in Xenopus. Dev Biol 408:196–204. https://doi.org/10.1016/j.ydbio.2015.11.003
Hwang WY, Fu Y, Reyon D et al (2013) Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31:227–229. https://doi.org/10.1038/nbt.2501
Nakayama T, Fish MB, Fisher M et al (2013) Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis. Genesis 51:835–843. https://doi.org/10.1002/dvg.22720
Deniz E, Jonas S, Hooper M et al (2017) Analysis of craniocardiac malformations in Xenopus using optical coherence tomography. Sci Rep 7:42506. https://doi.org/10.1038/srep42506
Zetsche B, Gootenberg JS, Abudayyeh OO et al (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163:759–771. https://doi.org/10.1016/j.cell.2015.09.038
Moreno-Mateos MA, Vejnar CE, Beaudoin J-D et al (2015) CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods 12:982–988. https://doi.org/10.1038/nmeth.3543
Kent WJ, Sugnet CW, Furey TS et al (2002) The human genome browser at UCSC. Genome Res 12:996–1006. https://doi.org/10.1101/gr.229102
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Deniz, E., Mis, E.K., Lane, M., Khokha, M.K. (2018). CRISPR/Cas9 F0 Screening of Congenital Heart Disease Genes in Xenopus tropicalis. In: Vleminckx, K. (eds) Xenopus. Methods in Molecular Biology, vol 1865. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8784-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8784-9_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8783-2
Online ISBN: 978-1-4939-8784-9
eBook Packages: Springer Protocols